Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Atr to promote regeneration and functional recovery after neural injury
$376,250Yuanquan Song · Children'S Hosp Of Philadelphia · R01 · FY2018 · NS
Translational Events in Platelets
$376,250Andrew Scott Weyrich · University Of Utah · R01 · FY2011 · HL
Translational Events in Platelets
$376,250Andrew Scott Weyrich · University Of Utah · R01 · FY2010 · HL
Targeting Atr to promote regeneration and functional recovery after neural injury
$376,250Yuanquan Song · Children'S Hosp Of Philadelphia · R01 · FY2019 · NS
Targeting Atr to promote regeneration and functional recovery after neural injury
$376,250Yuanquan Song · Children'S Hosp Of Philadelphia · R01 · FY2022 · NS
Targeting Atr to promote regeneration and functional recovery after neural injury
$376,250Yuanquan Song · Children'S Hosp Of Philadelphia · R01 · FY2020 · NS
Checkpoint control of cytokinesis
$376,225Kathleen L Gould · Vanderbilt University · R01 · FY2016 · GM
Checkpoint control of cytokinesis
$376,225Kathleen L Gould · Vanderbilt University · R01 · FY2014 · GM
Checkpoint control of cytokinesis
$376,225Kathleen L Gould · Vanderbilt University · R01 · FY2017 · GM
Checkpoint control of cytokinesis
$376,225Kathleen L Gould · Vanderbilt University · R01 · FY2015 · GM
CDC25 PHOSPHATASES IN CELL CYCLE CONTROL AND CANCER
$376,200Helen M Piwnica-Worms · Washington University · R01 · FY2010 · GM
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$376,197Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitors
$376,098Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$376,098Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2019 · CA
Individualized in situ vaccination by radiation and immunotherapy
$376,098Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
$376,098Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$376,075Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2022 · CA
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2022 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2023 · NS
Mouse Models of Tumor Progression and Therapy Response
$375,879Christopher J Kemp · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA
Long Noncoding RNA Advocates Immune Resistant Microenvironment
$375,816Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Roles of Lig3 and XRCC1 Genes in Genome Stability
$375,660Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2019 · ES
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$375,635Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2024 · CA
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods
$375,579Stephen J Salipante · University Of Washington · R33 · FY2019 · CA
Research Project 1: Enhancing neoadjuvant therapy to prevent breast cancer recurrence
$375,574Michael T Lewis · University Of Utah · U54 · FY2024 · CA